Law360, New York (October 19, 2009) -- The U.S. Court of Appeals for the Eighth Circuit is set to hear oral arguments Tuesday in a case that will decide whether failure-to-warn product liability claims against generic-drug manufacturers are preempted by federal law.
Gladys Mensing — who alleges that long-term ingestion of generic Reglan, a heartburn medication, caused her to develop the neurological movement disorder tardive dyskinesia — brought her suit against both...
